UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038545
Receipt number R000043926
Scientific Title Observational study on patients with mild cognitive impairment by using amyloid PET
Date of disclosure of the study information 2019/11/12
Last modified on 2021/03/03 15:05:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational study on patients with mild cognitive impairment by using amyloid PET

Acronym

Observational study on patients with mild cognitive impairment by using amyloid PET

Scientific Title

Observational study on patients with mild cognitive impairment by using amyloid PET

Scientific Title:Acronym

Observational study on patients with mild cognitive impairment by using amyloid PET

Region

Japan


Condition

Condition

mild cognitive impairment

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the relationship between amyloid PET-positive findings and the onset of Alzheimer-type dementia by conducting amyloid PET tests in patients with mild cognitive impairment and observing the subsequent course.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Detection rate of early dementia based on amyloid PET test

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Age at the time of obtaining consent is 20 years old or older, regardless of gender.
2. After verbal and written explanation, consent from the subject has been obtained in writing about participation.
3. Patients with mild cognitive impairment and clinically suspected Alzheimer type dementia as background pathology

Key exclusion criteria

1) Persons who are judged to be inappropriate by the person in charge or in charge of participation in this clinical study
2) Those who have an implantable device such as a pacemaker

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Manabu
Middle name
Last name Ikeda

Organization

Osaka University Graduate School

Division name

Department of Medicine, Department of Psychiatry

Zip code

565-0871

Address

2-2 D3, Yamadaoka, Suita City, Osaka Prefecture

TEL

0668793051

Email

mikeda@psy.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Masahiro
Middle name
Last name Hata

Organization

Osaka University Graduate School

Division name

Department of Medicine, Department of Psychiatry

Zip code

565-0871

Address

2-2 D3, Yamadaoka, Suita City, Osaka Prefecture

TEL

0668793051

Homepage URL


Email

mhata@psy.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University Clinical Research Review Committee

Address

2-2, Yamadaoka, Suita City, Osaka Prefecture

Tel

06-6210-8289

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 11 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 10 Month 25 Day

Date of IRB

2019 Year 10 Month 25 Day

Anticipated trial start date

2019 Year 11 Month 12 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study


Management information

Registered date

2019 Year 11 Month 11 Day

Last modified on

2021 Year 03 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043926


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name